These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35045168)

  • 1. Proximal tubular dysfunction in pregnant women receiving tenofovir disoproxil fumarate to prevent mother-to-child transmission of hepatitis B virus.
    Liegeon G; Ngo-Giang-Huong N; Salvadori N; Bunpo P; Cressey R; Achalapong J; Kanjanavikai P; Patamasingh Na Ayudhaya O; Prommas S; Siriwachirachai T; Sabsanong P; Yves Mary J; Jourdain G
    J Antimicrob Chemother; 2022 Mar; 77(4):1111-1118. PubMed ID: 35045168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
    Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
    BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial.
    Segeral O; Dim B; Durier C; Nhoueng S; Chhim K; Sovann S; Yom S; Vong C; Yin S; Ros B; Ky V; Pech S; Nem B; Hout K; Guillebaud J; Ear E; Caroupaye-Caroupin L; Rekacewicz C; Fernandez L; Laurent D; Yay C; Kim R; Meyer L; Chhun S;
    Lancet Infect Dis; 2022 Aug; 22(8):1181-1190. PubMed ID: 35643089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis.
    Funk AL; Lu Y; Yoshida K; Zhao T; Boucheron P; van Holten J; Chou R; Bulterys M; Shimakawa Y
    Lancet Infect Dis; 2021 Jan; 21(1):70-84. PubMed ID: 32805200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study.
    Thompson P; Morgan CE; Ngimbi P; Mwandagalirwa K; Ravelomanana NLR; Tabala M; Fathy M; Kawende B; Muwonga J; Misingi P; Mbendi C; Luhata C; Jhaveri R; Cloherty G; Kaba D; Yotebieng M; Parr JB
    Lancet Glob Health; 2021 Nov; 9(11):e1600-e1609. PubMed ID: 34416175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
    Jourdain G; Ngo-Giang-Huong N; Harrison L; Decker L; Khamduang W; Tierney C; Salvadori N; Cressey TR; Sirirungsi W; Achalapong J; Yuthavisuthi P; Kanjanavikai P; Na Ayudhaya OP; Siriwachirachai T; Prommas S; Sabsanong P; Limtrakul A; Varadisai S; Putiyanun C; Suriyachai P; Liampongsabuddhi P; Sangsawang S; Matanasarawut W; Buranabanjasatean S; Puernngooluerm P; Bowonwatanuwong C; Puthanakit T; Klinbuayaem V; Thongsawat S; Thanprasertsuk S; Siberry GK; Watts DH; Chakhtoura N; Murphy TV; Nelson NP; Chung RT; Pol S; Chotivanich N
    N Engl J Med; 2018 Mar; 378(10):911-923. PubMed ID: 29514030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate.
    Wen WH; Chen HL; Shih TT; Wu JF; Ni YH; Lee CN; Zhao LL; Lai MW; Mu SC; Tung YC; Hsu HY; Chang MH;
    J Hepatol; 2020 Jun; 72(6):1082-1087. PubMed ID: 32044401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Efficacy and Safety of Tenofovir Disoproxil Fumarate in Intercepting Mother-to-Child Transmission of Hepatitis B Virus.
    Han D; Du J; Wang W; Wang C
    Acta Med Okayama; 2024 Apr; 78(2):107-113. PubMed ID: 38688828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load.
    Li B; Liu Z; Liu X; Liu D; Duan M; Gu Y; Liu Q; Ma Q; Wei Y; Wang Y
    Hepatol Int; 2021 Oct; 15(5):1103-1108. PubMed ID: 34312798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenofovir for prevention of mother to child transmission of hepatitis B in migrant women in a resource-limited setting on the Thailand-Myanmar border: a commentary on challenges of implementation.
    Bierhoff M; Rijken MJ; Yotyingaphiram W; Pimanpanarak M; van Vugt M; Angkurawaranon C; Nosten F; Ehrhardt S; Thio CL; McGready R
    Int J Equity Health; 2020 Sep; 19(1):156. PubMed ID: 32912268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.
    Celen MK; Mert D; Ay M; Dal T; Kaya S; Yildirim N; Gulsun S; Barcin T; Kalkanli S; Dal MS; Ayaz C
    World J Gastroenterol; 2013 Dec; 19(48):9377-82. PubMed ID: 24409065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Tenofovir in the Prevention of Perinatal Transmission of Hepatitis B, a Meta-Analysis.
    Yang Q; Zhong Z; Yang Y; Ma Y; Flomo KT
    Gastroenterol Hepatol; 2020 Dec; 43(10):640-648. PubMed ID: 32948358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of tenofovir disoproxil fumarate in prevention of perinatal transmission of hepatitis B virus from mother to child: a systematic review and meta-analysis.
    Lee YS; Lee HS; Kim JH; Chang SW; Hyun MH; Bak H; Kim S; Lee MJ; Lee CU; Jung YK; Seo YS; Yim HJ; Yeon JE; Um SH; Byun KS
    Korean J Intern Med; 2021 Jan; 36(1):76-85. PubMed ID: 31878771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real-life practice.
    Liu J; Wang J; Yan T; Du D; Qi C; Cao F; Yao N; Yang Y; He Y; Tian Z; Ren D; Zhu L; Chen T; Zhao Y
    J Viral Hepat; 2019 Oct; 26(10):1170-1177. PubMed ID: 31177596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy.
    Bukkems VE; Smolders EJ; Jourdain G; Burger DM; Colbers AP; Cressey TR;
    J Clin Pharmacol; 2021 Mar; 61(3):388-393. PubMed ID: 32960984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of mother-to-child transmission of hepatitis B virus: protocol for a one-arm, open-label intervention study to estimate the optimal timing of tenofovir in pregnancy.
    Bierhoff M; Nelson KE; Guo N; Jia Y; Angkurawaranon C; Jittamala P; Carrara V; Watthanaworawit W; Ling C; Tongprasert F; van Vugt M; Rijken M; Nosten F; McGready R; Ehrhardt S; Thio CL
    BMJ Open; 2020 Sep; 10(9):e038123. PubMed ID: 32928858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of hepatitis B surface antigen in pregnant women with and without tenofovir disoproxil fumarate.
    Chang HL; Wen WH; Lee CN; Chiu YE; Liu CJ; Chang MH; Lin LH; Chen HL
    J Viral Hepat; 2022 Feb; 29(2):107-114. PubMed ID: 34724288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and safety of TAF, TDF, and LdT to prevent the transmission of hepatitis B in pregnant women: A retrospective study.
    Pan S; Zhang Y; Zeng Y; Lin C
    Immun Inflamm Dis; 2024 Feb; 12(2):e1204. PubMed ID: 38414328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus.
    Salvadori N; Fan B; Teeyasoontranon W; Ngo-Giang-Huong N; Phanomcheong S; Luvira A; Puangsombat A; Suwannarat A; Srirompotong U; Putiyanun C; Cressey TR; Decker L; Khamduang W; Harrison L; Tierney C; Shepherd JA; Kourtis AP; Bulterys M; Siberry GK; Jourdain G
    Clin Infect Dis; 2019 Jun; 69(1):144-146. PubMed ID: 30924492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study.
    Lampertico P; Buti M; Fung S; Ahn SH; Chuang WL; Tak WY; Ramji A; Chen CY; Tam E; Bae H; Ma X; Flaherty JF; Gaggar A; Lau A; Liu Y; Wu G; Suri V; Tan SK; Subramanian GM; Trinh H; Yoon SK; Agarwal K; Lim YS; Chan HLY
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):441-453. PubMed ID: 32087795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.